Consolidated Balance Sheets - USD ($) $ in Thousands		Jun. 30, 2024		Dec. 31, 2023
Assets
Cash and cash equivalents		$ 87,719		$ 52,591
Federal funds sold		70,242		97,254
Investment securities		55,830		54,282
Equity investments		10,795		11,430
Loans		2,385,590		2,215,886
Allowance for credit losses		(89,788)	[1]	(84,235)	[2]
Net loans receivable		2,295,802		2,131,651
Goodwill		150,803		150,803
Intangible assets, net		19,869		20,591
Property, equipment, and right-of-use lease asset, net		14,094		14,076
Accrued interest receivable		13,299		13,538
Loan collateral in process of foreclosure	[3]	9,359		11,772
Income tax receivable		3,290		671
Other assets		29,774		29,168
Total assets		2,760,876		2,587,827
Liabilities
Deposits	[4]	2,006,782		1,866,657
Long-term debt	[5]	230,803		235,544
Short-term borrowings		37,500		8,000
Deferred tax liabilities, net		22,394		21,207
Operating lease liabilities		6,071		7,019
Accrued interest payable		7,945		6,822
Accounts payable and accrued expenses	[6]	26,592		30,804
Total liabilities		2,338,087		2,176,053
Commitments and contingencies
Stockholders’ equity
Preferred stock (1,000,000 shares of $0.01 par value stock authorized-none outstanding)		0		0
Common stock (50,000,000 shares of $0.01 par value stock authorized - 29,262,204 shares at June 30, 2024 and 29,051,800 shares at December 31, 2023 issued)		293		291
Additional paid in capital		290,298		288,046
Treasury stock (6,050,214 shares at June 30, 2024 and 5,602,154 at December 31, 2023)		(49,179)		(45,538)
Accumulated other comprehensive loss		(3,744)		(3,696)
Retained earnings		116,333		103,883
Total stockholders’ equity		354,001		342,986
Non-controlling interest in consolidated subsidiaries		68,788		68,788
Total equity		422,789		411,774
Total liabilities and equity		$ 2,760,876		$ 2,587,827
Number of shares outstanding		23,211,990		23,449,646
Book value per share		$ 15.25		$ 14.63

[1] As of June 30, 2024 and June 30, 2023, there were no allowance for credit losses and net charge-offs related to the strategic partnership loans.

[2] 2023 beginning balance represents allowance prior to the adoption of ASU 2016-13.

[3] Includes financed sales of this collateral to third parties that are reported separately from the loan portfolio, of $5.3 million as of June 30, 2024 and $6.2 million as of December 31, 2023.

[4] Includes $4.6 million and $4.3 million of deferred financing costs as of June 30, 2024 and December 31, 2023. Refer to Note 5 for more details.

[5] Includes $4.0 million and $4.2 million of deferred financing costs as of June 30, 2024 and December 31, 2023. Refer to Note 5 for more details.

[6] Includes the short-term portion of lease liabilities of $2.3 million and $2.5 million as of June 30, 2024 and December 31, 2023. Refer to Note 6 for more details.